What is Medyria?
Headquartered in Switzerland with additional operations in Portugal, Medyria occupies a critical niche in the medical technology landscape. The company specializes in high-precision sensing components that provide real-time physiological data, which are essential for modern interventional cardiology procedures. Their flagship innovation, the PyCath, serves as a comprehensive stand-alone device designed to enhance diagnostic accuracy during complex cardiac interventions. By offering their sensing technology as an OEM component, Medyria effectively integrates its proprietary solutions into broader medical device ecosystems, thereby establishing a scalable business model that bridges the gap between raw physiological measurement and clinical application.
How much funding has Medyria raised?
Medyria has raised a total of $2.4M across 1 funding round:
Series A
$2.4M
Series A (2015): $2.4M with participation from Fongit SeedInvest SA
Key Investors in Medyria
Fongit SeedInvest SA
Fongit SeedInvest SA is a prominent innovation platform based in Geneva that provides specialized coaching, legal support, and early-stage financing to high-potential startups.
What's next for Medyria?
Following this major enterprise-level funding, Medyria is expected to prioritize the scaling of its manufacturing capabilities and the expansion of its clinical footprint. The strategic allocation of these resources will likely focus on deepening the market penetration of the PyCath device while simultaneously refining its OEM sensor offerings to meet the evolving demands of global cardiology providers. As the company transitions from its initial development phase into a more mature commercial entity, the focus will shift toward regulatory milestones and the establishment of strategic partnerships with major medical device manufacturers. This trajectory suggests a robust outlook for Medyria as it seeks to standardize its blood flow velocity sensing technology as a benchmark for physiological assessment in cardiac care.
See full Medyria company page
